The Pharmacy Times® Oncology resource center provides clinical news and articles, information about upcoming conferences and meetings, updated clinical trial listings, and other resources.
What can we help you find?
Several recent studies presented at the virtual SGO 2020 Annual Meeting on Women’s Cancer looked into veliparib, a potential anticancer PARP inhibitor, for treatment of various types of ovarian cancer.
By using a non-invasive screening model, care providers can help catch and treat more cases of colorectal cancer, a new study suggests.
Study examines the effect of a low-calorie, plant-based diet combined with vitamin C in helping to kill cancer cells.
Cancer care providers have increasingly been using biosimilars on a case-by-case basis with patients.
The clinical trial of teclistamab sought to identify a recommended phase 2 dose for patients with RRMM, with multiple IV doses and priming doses explored.
A review of the potential agents or regimens that Allison Butts, PharmD, BCOP, is looking forward to seeing transition from metastatic management to the early stage setting.
A recent study evaluated the efficacy of venetoclax monotherapy in participants with relapsed or refractory chronic lymphocytic leukemia.
With the groundbreaking advancements in specialty pharmacy, it is important to recognize the uniqueness of these medications and their respective patient populations.
The American Cancer Society is renewing efforts to increase HPV immunization as COVID-19 threatens to slow cancer prevention progress.
In the United States, these findings would translate to more than 269,000 prevented breast cancer cases and nearly 44,000 prevented cases of ovarian cancer.
Experts in the field of breast cancer management review the data from the ExteNET and TRAIN-2 Trials.
As the most accessible member of the health care team, the pharmacist can provide patients with cancer with the information and support necessary to get through what might be the most challenging time of their lives.